NCT01938508View on ClinicalTrials.gov

Minocycline Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Skin Diseases
Interventions
DRUG

Minocycline

minocycline hydrochloride capsules in microgranules equivalent to 100 mg of minocycline

Trial Locations (1)

03100

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

CECYC (Center of Scientific and Clinical Studies, CRO)

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY

NCT01938508 - Minocycline Bioequivalence Study | Biotech Hunter | Biotech Hunter